There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK – Research Report) and Regeneron ......

In a report released today, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron, with a price target of $850.00. According to TipR......

Wells Fargo analyst Mohit Bansal maintained a Hold rating on Regeneron yesterday and set a price target of $745.00. According to TipRanks, Bansal i......

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Regeneron, with a price target of $708.00. According to Tip......

The Invesco QQQ ETF ($QQQ) rose 0.81% on Friday, with major indices ending the last trading session of November on a positive note. However, Novemb......

Analysts are intrested in these 5 stocks: ( ($EXAS) ), ( ($REGN) ), ( ($MRVL) ), ( ($FROG) ) and ( ($JAZZ) ). Here is a breakdown of their recent ...

The Invesco QQQ ETF ($QQQ) rose 0.88% on Wednesday as major averages closed higher for the fourth straight day, ahead of the Thanksgiving holiday. ......

Scotiabank analyst Louise Chen maintained a Hold rating on Regeneron today and set a price target of $770.00. Chen covers the Healthcare sector, fo......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN – Research Report), Gilead Sciences ......

Several pharmaceutical companies awaiting a decision from U.S. authorities on their drug applications are set to get them this month. These decisio......